Ares Management ARES

Reference table

1. What it is

Ares Management (NYSE: ARES) is a Los Angeles–based global alternative asset manager, founded 1997, IPO'd 2014. It runs money across four engines: Tradable Credit (liquid non-investment-grade corporate credit — CLOs, loans, pooled and separately managed accounts), Direct Lending (private credit to small- and mid-sized companies — its flagship franchise), Private Equity (control/co-control positions in under-capitalized businesses), and Real Estate (development, repositioning, and specialty financing). Per the Q1'26 release, total AUM is $644.3B, Fee-Paying AUM $399.6B, available "dry powder" capital $158.1B. Fiscal year ends December 31. CEO/co-founder Michael Arougheti.

Why the GAAP income statement looks weird. Ares consolidates many of the funds it manages, so its GAAP revenue ($6.47B FY25) and GAAP EPS ($1.96) are distorted by fund-level items and large minority interest. The numbers management, analysts, and this note actually track are the non-GAAP ones: Fee Related Earnings (FRE) and Realized Income (RI). Q1'26: FRE $464.4M, RI $502.7M, after-tax RI $1.24/share. Read the "EPS" in the estimates table below as adjusted EPS, not GAAP.

Revenue mix (FY2025 product segmentation, from filings):

• Management Service (recurring management fees) $3.73B (58%) — the durable core.
• Carried Interest $1.19B (18%) — profit-share, market-sensitive.
• Administrative Service $0.37B · Management Service Incentive $0.36B · Principal Investment Income $0.14B.
• Read: the majority of revenue is recurring management fees (good), but ~18%+ is carry/incentive that swings with markets and realizations (cyclical).

Geographic segmentation is not broken out in the FMP feed (seg_geo empty); the firm operates across the US, Europe, and Asia.

2. The expert thesis — a genuine bull-vs-bear split (traceable)

Honest coverage note: the Synthos KB has only 5 claims on ARES, and they do not agree. This is not a high-conviction, broad-panel name like our flagship compounders. The verdict here is primarily fundamentals- and quant-driven, with the two named voices used as guardrails, not as an anchor. Both sides are on record:

• The bull (structural). Business Breakdowns (business_breakdowns-Haj78lrOlbI:9fbc1a8270, bullish, conviction 80): top-tier BDCs and private-credit vehicles are "now institutional-quality products investing alongside vetted private funds — the old Einhorn-era 'nefarious scheme' view is outdated." The thesis: private credit has matured into a legitimate, durable asset class, and scaled managers like Ares are the toll-collectors.
• The bear (cyclical, and dated recently). Jordi Visser (jordi_visser_ai-urLT0eDzoaw:abb62440df, bearish, conviction 78, dated 2025-10-12): "Private equity and the $1.7T private-credit market are cracking; BDCs and PE names have fallen violently, signaling widening junk spreads." This is the more recent voice, and the ~40% drawdown in ARES is consistent with exactly the stress he describes.

Honest composite. Net-bullish voices = 1, but the signed picture is essentially a draw: a structural bull vs. a recent, credible cyclical bear. We do not manufacture conviction from a split panel. The tie-breaker is the data — cheap forward multiple + recurring fee base (bull) vs. leverage + credit-cycle timing (bear) — which is why this lands as a small, tactical call rather than a core one.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities. All EPS figures are adjusted (After-tax RI basis), consistent with the estimate feed.

Synthos fair value = the base case, ~$176 (+50%), with the full $96–$240 span as the honest range — a wide range by design, because this is a cyclical whose outcome hinges on one macro variable (the credit cycle). This anchor sits essentially in line with the Street's $171 consensus. Note the asymmetry: the upside is large if the cycle holds, but the bear is a genuine −18% (and the drawdown to date shows the downside is real). This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). ARES is a cyclical fee compounder, not a secular exponential:

• Forward growth: on the analyst feed, adjusted revenue CAGR FY25→FY29E is ~27% and adjusted-EPS CAGR ~17% ($5.00 → $9.26). Solid, but partly a recovery off a depressed base.
• Acceleration (2nd derivative): adjusted-EPS growth runs +20% (FY26E) → +23% (FY27E) → +18% (FY28E) → +7% (FY29E) — i.e. steady-to-decelerating, and critically cycle-dependent rather than structurally accelerating. The FY29 revenue jump in the feed leans on only two analysts, so treat the tail as noisy.
• Room to run: the private-credit / direct-lending TAM is genuinely large and still taking share from banks — the demand runway is real. At a $38B market cap Ares is mid-size (a fraction of Apollo's $68B or Morgan Stanley's $337B), so there is room to grow into the category. But cyclicality caps the "exponential" label: a credit downturn resets AUM growth and carry.
• Reinvestment / flywheel: AUM growth → fee growth → more capital raised is a real flywheel in good times; it runs in reverse in a credit contraction.

Exponential Potential: Moderate (5). Own it for a cyclical-recovery + fee-compounding tilt, not for a fast, all-weather multibagger. The honest framing is why ARES is a satellite, not a core.

5. Financials (real numbers — FMP annual/quarterly; note GAAP vs. adjusted)

• GAAP revenue (consolidated): FY25 $6.47B (vs $3.88B FY24) — inflated/distorted by fund consolidation; not the right growth read.
• The measures that matter (from the Q1'26 release): AUM $644.3B, FPAUM $399.6B, dry powder $158.1B; Q1'26 FRE $464.4M, RI $502.7M, after-tax RI $1.24/share; Q1'26 unconsolidated management + other fees $1,075.5M (management fees $989.5M, +21% YoY vs $817M). The recurring fee engine is clearly growing.
• GAAP earnings: FY25 net income attributable to Ares was $426M, GAAP EPS $1.96 — low because of minority interest and carry accounting, which is why the 52× "P/E" is not the right lens.
• Margins (GAAP TTM): gross ~71%, EBITDA margin ~38%, net ~10%. On a fee basis, FRE margins are healthy (~43% of the fee base in Q1'26).
• Cash flow: FY25 operating cash flow $3.27B, FCF $3.19B — genuinely strong and covers the ~$1.76B of common dividends paid. (Note FY23 operating CF was negative due to fund/working-capital swings — cash flow here is lumpy, a cyclicality tell.)
• Balance sheet: total debt $14.9B, net debt $13.4B, net-debt/EBITDA 5.3× — high, and the key risk marker. Cash $1.5B. There is also $1.46B of preferred stock (Series B mandatory convertible) in the capital structure.

6. Valuation — cheap on the right metric, not the wrong one

Do not use the 52× trailing GAAP P/E — for a consolidating alt-manager it's meaningless. On the measure the Street and management use (adjusted / After-tax RI EPS), the forward multiples are ~23× FY26E ($6.00) → ~16× FY27E ($7.37) → ~13× FY28E ($8.70) — i.e. the multiple compresses quickly if estimates hit, and ~16× FY27 is reasonable-to-cheap for a ~20% fee compounder. EV/EBITDA is 21×, P/B 6.5×, and the dividend yield is ~4.2% ($4.94). The FMP letter rating is C (score 2/10) — but that model is anchored on GAAP P/E, P/B, and debt/equity, all of which read punitively for a levered alt-manager; it materially understates the fee-earnings quality. Street targets (context): consensus $171.13, high $215, low $140, median $164 — our $176 base sits right on top of consensus. The honest read: not expensive on forward adjusted earnings; the entire debate is whether those earnings hold through the credit cycle — a macro call, not a multiple call.

7. Technicals (from the tech block)

• Trend: down. $116.90 sits below the 50-DMA ($122.7) and the 200-DMA ($138.2), and the 50 is below the 200 (death-cross posture). MACD −3.4 (negative).
• Location: −39.4% off the 52-week high ($192.76), +21% off the 52-week low ($96.56); max drawdown −41% from peak — a deeply corrected name.
• Momentum: RSI(14) 31 — near oversold (<30 is classic oversold), consistent with a washed-out, mean-reversion setup.
• Relative strength (the tell): ARES −33.1% 12-mo vs SPY +20.6% and QQQ +30.3% — massive underperformance over the year. But note the +10.5% 3-mo bounce (vs SPY +13.7%) — early signs of stabilization, though still lagging.
• Read: technicals describe a beaten-down, oversold name that is starting to base but has not confirmed a trend reversal (still below both moving averages). This supports a tactical, scale-in entry — not an all-clear. A reclaim of the 50-DMA (~$123) would be the first confirmation.

8. Moat & competitive position

Ares' moat is scale, track record, and fund-raising machinery in a category (private credit / direct lending) that is still taking share from retreating banks. Scaled incumbents with long performance histories and deep LP relationships raise capital more cheaply and win the largest deals — a real barrier for sub-scale entrants. The Business Breakdowns bull (business_breakdowns-Haj78lrOlbI:9fbc1a8270) is precisely this: private credit has become an institutional-quality product, and the toll-collectors benefit. The moat's limit: it is a cyclical moat — durable in expansions, tested in credit contractions, when defaults, mark-downs, and slowing fundraising hit fees and carry simultaneously (the Visser bear).

Peer set (from the feed, market cap): Apollo Global $68B (the closest large alt-manager comp), Blue Owl Capital $14B (direct-lending pure-play), Morgan Stanley $337B, State Street $47B, Raymond James $32B, SoFi $23B, Brown & Brown $24B, Huntington Bancshares $36B. Against Apollo and Blue Owl — the truest comps — Ares is the mid-cap alt-credit specialist; its ~40% drawdown has been broadly shared across the private-credit cohort, which is the market voting on the Visser thesis.

9. Management, capital allocation & guidance

• Capital allocation: returns cash aggressively — ~$1.76B of common dividends in FY25 ($4.94/share, ~4.2% yield) — while funding growth (the Feb-2026 BlueCove acquisition, a London systematic fixed-income manager, added $5.5B AUM). The dividend is not covered by GAAP EPS and is paid from adjusted cash earnings; that's normal for the model but means a realization/fee air-pocket pressures the payout. No buyback in FY25.
• Insider activity: the signal is mixed-to-encouraging. Two directors bought on the open market in Feb-2026 near the lows (Bhutani +10,000 sh @ ~$126.61; Olian +480 sh @ ~$124.43) — insider purchases are relatively rare and constructive. The General Counsel made small routine sales in Feb-2026, and the CEO's most recent Form 4 (2026-07-02) was an F-InKind tax-withholding disposition (82,957 sh), not a discretionary sale. No alarming cluster of discretionary selling.
• Management's own guidance (half-weighted — their own book): the SEC 8-K earnings release (filed 2026-05-01, Q1'26) is a real earnings presentation and reports management's own operating scorecard — AUM $644.3B, FPAUM $399.6B, $158.1B available capital, $79.4B AUM not yet paying fees ("shadow" fee growth), $29.5B raised in the quarter with $27.9B net inflows, $32.3B deployed, FRE $464.4M, after-tax RI $1.24/share, quarterly dividend $1.35. Management frames this as continued fundraising and deployment momentum. Treat as self-interested (half-weight): the same release does not headline any credit-quality deterioration, which is exactly the variable the bear cares about. Ares does not issue explicit forward EPS/revenue guidance; the forward numbers in this note are analyst estimates, labeled as such.

10. Catalysts & what to watch

• Next earnings: 2026-07-31 (Q2'26; Street EPS $1.35, revenue ~$1.33B). The lines that matter: FRE growth, gross inflows/net inflows, deployment pace, and — above all — any credit-quality / non-accrual commentary in the direct-lending book.
• Private-credit spreads & defaults: the single biggest macro swing factor — the Visser bear thesis lives or dies here. Watch high-yield/loan spreads and BDC-sector non-accruals.
• Fundraising trajectory: the $79.4B of AUM-not-yet-paying-fees is embedded future fee growth — watch it convert (or stall).
• Dividend coverage: whether after-tax RI comfortably covers the $1.35 quarterly payout through any slowdown.
• Rate path: direct-lending economics and realization activity are rate-sensitive.

Thesis tripwires (what would change the call): rising non-accruals / credit marks in the lending book; two consecutive quarters of net outflows; FRE growth stalling; or the dividend outrunning after-tax RI. Any of these flips this from Tactical toward Avoid.

11. Key risks

• Credit cycle (structural, and live): the core risk — a private-credit / direct-lending downturn hits fees, carry, and the levered balance sheet at once. The most recent expert voice we track is explicitly bearish on exactly this (jordi_visser_ai-urLT0eDzoaw:abb62440df, 2025-10-12).
• Leverage: net-debt/EBITDA 5.3× and debt/equity 3.5× amplify any downturn; there's little balance-sheet cushion.
• Cyclical / lumpy earnings: carry and realizations swing with markets; FY23 operating cash flow was negative — cash generation is not smooth.
• Dividend not GAAP-covered: a fee/realization air-pocket pressures a ~4.2% yield that income investors are relying on.
• Beta / drawdown: beta 1.52 and a −41% peak-to-trough show this trades like a high-beta credit proxy, not a defensive.
• Thin, split expert coverage: we have one bull and one bear and nothing else — low conviction by construction.

12. Verdict, position sizing & monitoring

Buy — Tactical. ARES is a genuinely good business (scaled alt-credit manager, $644B AUM, growing recurring fees) that has been cut ~40% and now trades cheap on the right metric (~16× FY27E adjusted EPS, ~4.2% yield) while sitting oversold (RSI 31, near a base). That is a real mean-reversion / value setup, and the +50% to our $176 base (in line with the $171 Street) is attractive if the credit cycle holds. But we will not dress this up as a core conviction call: the KB is a draw (one structural bull, one recent credible bear), the balance sheet is levered 5.3×, and the whole thesis rides on one macro variable. That combination is a small tactical position, not a flagship core weight.

• Sizing: tactical satellite, ~1–3% — a scale-in on weakness (starter now; add on a reclaim of the 50-DMA ~$123 or on a confirmed credit-quality all-clear). Not a size-up-and-forget holding.
• Monitoring: re-underwrite on the §10 tripwires — especially non-accruals and net flows — and formally re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $116.90.
• Single biggest risk: a private-credit credit cycle — the one variable that turns the bull thesis into the bear's in a single quarter.

Provenance & disclosures

• Traceability: 5 KB claims, breadth 1 net-bullish (one bull + one bear), last claim 2025-10-12 — both cited inline and reconciled to real claim_ids. This is a thin, split panel; the verdict is fundamentals- and quant-driven, with the experts as guardrails. Fabricated conviction is structurally impossible (claim-ID reconciliation).
• GAAP vs. adjusted caveat: trailing GAAP P/E (52×) is not meaningful for a consolidating alt-manager; forward multiples and scores use adjusted (After-tax Realized Income) EPS from the analyst feed. Adjusted figures are estimates, labeled as such.
• Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · expert claims through 2025-10-12. Forward figures are analyst consensus (FMP), labeled as estimates.
• Management caveat: the Q1'26 SEC 8-K earnings release is management's own book, half-weighted by design; Ares issues no explicit forward EPS/revenue guidance.
• Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
• Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").